0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Research Report 2023
Published Date: November 2023
|
Report Code: QYRE-Auto-7E13755
Home | Market Reports | Health| Health Conditions| Cancer
Global Medicine for the Treatment of Advanced Thyroid Cancer Market Research Report 2023
BUY CHAPTERS

Global Medicine for the Treatment of Advanced Thyroid Cancer Market Research Report 2023

Code: QYRE-Auto-7E13755
Report
November 2023
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medicine for the Treatment of Advanced Thyroid Cancer Market Size

According to new survey, global Medicine for the Treatment of Advanced Thyroid Cancer market is projected to reach US$ 666.6 million in 2029, increasing from US$ 438 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2029.

Medicine for the Treatment of Advanced Thyroid Cancer Market

Medicine for the Treatment of Advanced Thyroid Cancer Market

Thyroid cancer is the most common endocrine tumor. Four targeted agents (vandetanib, cabozantinib, sorafenib, and lenvatinib) have attained regulatory approval for advanced thyroid cancer, and several other related agents are now commonly used off-label as first- and second-line treatments for selected patients.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medicine for the Treatment of Advanced Thyroid Cancer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Medicine for the Treatment of Advanced Thyroid Cancer Market Report

Report Metric Details
Report Name Medicine for the Treatment of Advanced Thyroid Cancer Market
Accounted market size in 2022 US$ 438 million
Forecasted market size in 2029 US$ 666.6 million
CAGR 6.3%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Cabozantinib
  • Sorafenib
  • Vandetanib
  • Lenvatinib
Segment by Application
  • Combination therapy
  • Solo Medication
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, AstraZeneca, Sanofi, Exelixis Inc., Ipsen Pharma, Eisai Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Medicine for the Treatment of Advanced Thyroid Cancer Market growing?

Ans: The Medicine for the Treatment of Advanced Thyroid Cancer Market witnessing a CAGR of 6.3% during the forecast period 2023-2029.

What is the Medicine for the Treatment of Advanced Thyroid Cancer Market size in 2029?

Ans: The Medicine for the Treatment of Advanced Thyroid Cancer Market size in 2029 will be US$ 666.6 million.

Who are the main players in the Medicine for the Treatment of Advanced Thyroid Cancer Market report?

Ans: The main players in the Medicine for the Treatment of Advanced Thyroid Cancer Market are Bayer, AstraZeneca, Sanofi, Exelixis Inc., Ipsen Pharma, Eisai Inc

What are the Application segmentation covered in the Medicine for the Treatment of Advanced Thyroid Cancer Market report?

Ans: The Applications covered in the Medicine for the Treatment of Advanced Thyroid Cancer Market report are Combination therapy, Solo Medication

What are the Type segmentation covered in the Medicine for the Treatment of Advanced Thyroid Cancer Market report?

Ans: The Types covered in the Medicine for the Treatment of Advanced Thyroid Cancer Market report are Cabozantinib, Sorafenib, Vandetanib, Lenvatinib

1 Medicine for the Treatment of Advanced Thyroid Cancer Market Overview
1.1 Product Overview and Scope of Medicine for the Treatment of Advanced Thyroid Cancer
1.2 Medicine for the Treatment of Advanced Thyroid Cancer Segment by Type
1.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Type (2023-2029)
1.2.2 Cabozantinib
1.2.3 Sorafenib
1.2.4 Vandetanib
1.2.5 Lenvatinib
1.3 Medicine for the Treatment of Advanced Thyroid Cancer Segment by Application
1.3.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value by Application: (2023-2029)
1.3.2 Combination therapy
1.3.3 Solo Medication
1.4 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size Estimates and Forecasts
1.4.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue 2018-2029
1.4.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales 2018-2029
1.4.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medicine for the Treatment of Advanced Thyroid Cancer Market Competition by Manufacturers
2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Average Price by Manufacturers (2018-2023)
2.4 Global Medicine for the Treatment of Advanced Thyroid Cancer Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Product Type & Application
2.7 Medicine for the Treatment of Advanced Thyroid Cancer Market Competitive Situation and Trends
2.7.1 Medicine for the Treatment of Advanced Thyroid Cancer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medicine for the Treatment of Advanced Thyroid Cancer Players Market Share by Revenue
2.7.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medicine for the Treatment of Advanced Thyroid Cancer Retrospective Market Scenario by Region
3.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region: 2018-2029
3.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region: 2018-2023
3.2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region: 2024-2029
3.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2018-2029
3.3.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2018-2023
3.3.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2024-2029
3.4 North America Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.4.1 North America Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2018-2029)
3.4.3 North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.5.1 Europe Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2018-2029)
3.5.3 Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.6.1 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2018-2029)
3.6.3 Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.7.1 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2018-2029)
3.7.3 Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Market Facts & Figures by Country
3.8.1 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Type (2018-2029)
4.1.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Type (2018-2023)
4.1.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Type (2024-2029)
4.1.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Type (2018-2029)
4.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Type (2018-2029)
4.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Type (2018-2023)
4.2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Type (2024-2029)
4.2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Type (2018-2029)
4.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Application (2018-2029)
5.1.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Application (2018-2023)
5.1.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Application (2024-2029)
5.1.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Application (2018-2029)
5.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Application (2018-2029)
5.2.1 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Application (2018-2023)
5.2.2 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Application (2024-2029)
5.2.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Application (2018-2029)
5.3 Global Medicine for the Treatment of Advanced Thyroid Cancer Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Exelixis Inc.
6.4.1 Exelixis Inc. Corporation Information
6.4.2 Exelixis Inc. Description and Business Overview
6.4.3 Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.4.5 Exelixis Inc. Recent Developments/Updates
6.5 Ipsen Pharma
6.5.1 Ipsen Pharma Corporation Information
6.5.2 Ipsen Pharma Description and Business Overview
6.5.3 Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.5.5 Ipsen Pharma Recent Developments/Updates
6.6 Eisai Inc
6.6.1 Eisai Inc Corporation Information
6.6.2 Eisai Inc Description and Business Overview
6.6.3 Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Product Portfolio
6.6.5 Eisai Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medicine for the Treatment of Advanced Thyroid Cancer Industry Chain Analysis
7.2 Medicine for the Treatment of Advanced Thyroid Cancer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medicine for the Treatment of Advanced Thyroid Cancer Production Mode & Process
7.4 Medicine for the Treatment of Advanced Thyroid Cancer Sales and Marketing
7.4.1 Medicine for the Treatment of Advanced Thyroid Cancer Sales Channels
7.4.2 Medicine for the Treatment of Advanced Thyroid Cancer Distributors
7.5 Medicine for the Treatment of Advanced Thyroid Cancer Customers
8 Medicine for the Treatment of Advanced Thyroid Cancer Market Dynamics
8.1 Medicine for the Treatment of Advanced Thyroid Cancer Industry Trends
8.2 Medicine for the Treatment of Advanced Thyroid Cancer Market Drivers
8.3 Medicine for the Treatment of Advanced Thyroid Cancer Market Challenges
8.4 Medicine for the Treatment of Advanced Thyroid Cancer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Medicine for the Treatment of Advanced Thyroid Cancer Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Medicine for the Treatment of Advanced Thyroid Cancer, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Product Type & Application
    Table 12. Global Key Manufacturers of Medicine for the Treatment of Advanced Thyroid Cancer, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Medicine for the Treatment of Advanced Thyroid Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine for the Treatment of Advanced Thyroid Cancer as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2018-2023) & (K Units)
    Table 18. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Region (2018-2023)
    Table 19. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2024-2029) & (K Units)
    Table 20. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Region (2024-2029)
    Table 21. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Region (2018-2023)
    Table 23. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Region (2024-2029)
    Table 25. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2018-2023) & (K Units)
    Table 27. North America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2024-2029) & (K Units)
    Table 28. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Type (2018-2023)
    Table 51. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Type (2024-2029)
    Table 52. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Type (2018-2023)
    Table 53. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Type (2024-2029)
    Table 54. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Type (2018-2023)
    Table 57. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Type (2024-2029)
    Table 58. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Application (2018-2023)
    Table 61. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units) by Application (2024-2029)
    Table 62. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Application (2018-2023)
    Table 63. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Application (2024-2029)
    Table 64. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Application (2018-2023)
    Table 67. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Application (2024-2029)
    Table 68. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Application (2024-2029)
    Table 70. Bayer Corporation Information
    Table 71. Bayer Description and Business Overview
    Table 72. Bayer Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. Bayer Medicine for the Treatment of Advanced Thyroid Cancer Product
    Table 74. Bayer Recent Developments/Updates
    Table 75. AstraZeneca Corporation Information
    Table 76. AstraZeneca Description and Business Overview
    Table 77. AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. AstraZeneca Medicine for the Treatment of Advanced Thyroid Cancer Product
    Table 79. AstraZeneca Recent Developments/Updates
    Table 80. Sanofi Corporation Information
    Table 81. Sanofi Description and Business Overview
    Table 82. Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Sanofi Medicine for the Treatment of Advanced Thyroid Cancer Product
    Table 84. Sanofi Recent Developments/Updates
    Table 85. Exelixis Inc. Corporation Information
    Table 86. Exelixis Inc. Description and Business Overview
    Table 87. Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Exelixis Inc. Medicine for the Treatment of Advanced Thyroid Cancer Product
    Table 89. Exelixis Inc. Recent Developments/Updates
    Table 90. Ipsen Pharma Corporation Information
    Table 91. Ipsen Pharma Description and Business Overview
    Table 92. Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Ipsen Pharma Medicine for the Treatment of Advanced Thyroid Cancer Product
    Table 94. Ipsen Pharma Recent Developments/Updates
    Table 95. Eisai Inc Corporation Information
    Table 96. Eisai Inc Description and Business Overview
    Table 97. Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. Eisai Inc Medicine for the Treatment of Advanced Thyroid Cancer Product
    Table 99. Eisai Inc Recent Developments/Updates
    Table 100. Key Raw Materials Lists
    Table 101. Raw Materials Key Suppliers Lists
    Table 102. Medicine for the Treatment of Advanced Thyroid Cancer Distributors List
    Table 103. Medicine for the Treatment of Advanced Thyroid Cancer Customers List
    Table 104. Medicine for the Treatment of Advanced Thyroid Cancer Market Trends
    Table 105. Medicine for the Treatment of Advanced Thyroid Cancer Market Drivers
    Table 106. Medicine for the Treatment of Advanced Thyroid Cancer Market Challenges
    Table 107. Medicine for the Treatment of Advanced Thyroid Cancer Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Medicine for the Treatment of Advanced Thyroid Cancer
    Figure 2. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Type in 2022 & 2029
    Figure 4. Cabozantinib Product Picture
    Figure 5. Sorafenib Product Picture
    Figure 6. Vandetanib Product Picture
    Figure 7. Lenvatinib Product Picture
    Figure 8. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Application in 2022 & 2029
    Figure 10. Combination therapy
    Figure 11. Solo Medication
    Figure 12. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Medicine for the Treatment of Advanced Thyroid Cancer Sales (2018-2029) & (K Units)
    Figure 15. Global Medicine for the Treatment of Advanced Thyroid Cancer Average Price (US$/Unit) & (2018-2029)
    Figure 16. Medicine for the Treatment of Advanced Thyroid Cancer Report Years Considered
    Figure 17. Medicine for the Treatment of Advanced Thyroid Cancer Sales Share by Manufacturers in 2022
    Figure 18. Global Medicine for the Treatment of Advanced Thyroid Cancer Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Medicine for the Treatment of Advanced Thyroid Cancer Players: Market Share by Revenue in 2022
    Figure 20. Medicine for the Treatment of Advanced Thyroid Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Medicine for the Treatment of Advanced Thyroid Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2018-2029)
    Figure 23. North America Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2018-2029)
    Figure 24. U.S. Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2018-2029)
    Figure 27. Europe Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Region (2018-2029)
    Figure 35. China Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Taiwan Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Indonesia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Thailand Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Malaysia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Philippines Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2018-2029)
    Figure 46. Latin America Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2018-2029)
    Figure 47. Mexico Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Brazil Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Argentina Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Sales Market Share by Country (2018-2029)
    Figure 51. Middle East & Africa Medicine for the Treatment of Advanced Thyroid Cancer Revenue Market Share by Country (2018-2029)
    Figure 52. Turkey Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. UAE Medicine for the Treatment of Advanced Thyroid Cancer Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Global Sales Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Type (2018-2029)
    Figure 56. Global Revenue Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Type (2018-2029)
    Figure 57. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Type (2018-2029)
    Figure 58. Global Sales Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Application (2018-2029)
    Figure 59. Global Revenue Market Share of Medicine for the Treatment of Advanced Thyroid Cancer by Application (2018-2029)
    Figure 60. Global Medicine for the Treatment of Advanced Thyroid Cancer Price (US$/Unit) by Application (2018-2029)
    Figure 61. Medicine for the Treatment of Advanced Thyroid Cancer Value Chain
    Figure 62. Medicine for the Treatment of Advanced Thyroid Cancer Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Hurthle Cell Carcinoma Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35B1140
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Oncology Based Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6P7589
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global Internal Radiation Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17G14298
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global External beam Radiation Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5C14164
Thu Feb 08 00:00:00 UTC 2024

Add to Cart